Lumos Pharma Inc (NAS:LUMO)
$ 4.38 0.08 (1.86%) Market Cap: 37.88 Mil Enterprise Value: 23.84 Mil PE Ratio: 0 PB Ratio: 7.68 GF Score: 48/100

Q3 2022 Lumos Pharma Inc Interim Analysis & Earnings Call Transcript

Nov 14, 2022 / 01:30PM GMT
Release Date Price: $5.82 (-34.68%)
Operator

Good morning, and welcome to Lumos Pharma's interim data update conference call. (Operator Instructions) As a reminder, this conference call is being recorded.

I will now turn the call over to Lisa Miller, Senior Director of Investor Relations. Please go ahead, ma'am.

Lisa Miller
Lumos Pharma, Inc. - Senior Director of IR

Thank you, operator. Before we proceed with the call, I would like to remind everyone that certain statements made during this call are forward-looking statements under U.S. federal securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. Additional information concerning factors that could cause actual results to differ is contained in our periodic reports filed with the SEC.

The forward-looking statements made during this call speak only as of the date hereof, and the company undertakes no obligation to update or revise the forward-looking statements. Information presented on this call is contained in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot